Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial

Alison Tree, Victoria Hinder, Shaun Tolan, Peter Ostler, H. van der Voet, Kiran Kancherla, Andrew Loblaw, Olivia Naismith, Suneil Jain, Alexander Martin,

The Lancet Oncology · 2025 · 26 citations · 23 references

DOIFull text

Open access

Concepts

References

23